Kiniksa Pharmaceuticals International, plc
KNSA
$76.75
-$1.08-1.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 42.62% | 164.57% | 259.75% | 245.24% | 556.29% |
| Total Depreciation and Amortization | 31.84% | 35.65% | 16.75% | -3.76% | -16.74% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.35% | 42.06% | 98.68% | 256.42% | -37.67% |
| Change in Net Operating Assets | 452.22% | 545.28% | 25.99% | -118.15% | 83.19% |
| Cash from Operations | 68.01% | 124.87% | 187.13% | 1,606.13% | 443.54% |
| Capital Expenditure | -301.82% | -62.63% | -227.98% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,861.19% | 38.27% | -207.17% | -878.01% | 92.06% |
| Cash from Investing | -1,794.93% | 38.08% | -208.46% | -888.58% | 91.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 37.92% | 100.91% | 215.29% | 72.88% | 1,022.91% |
| Repurchase of Common Stock | -167.12% | 23.30% | -58.82% | -60.51% | -55.90% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 13.20% | 119.40% | 257.52% | 77.89% | 6,110.11% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -140.90% | 192.09% | -110.74% | -806.54% | 183.49% |